Ładuje się......
Immunotherapy for Prostate Cancer: Where We Are Headed
Prostate cancer is one of the most common malignant neoplasms in men worldwide, and is the fifth cause of cancer-related death. In recent years, a new generation of therapies have been approved for the management of metastatic disease. Moreover, the development of new immunotherapeutic drugs has bec...
Zapisane w:
| Wydane w: | Int J Mol Sci |
|---|---|
| Główni autorzy: | , , , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
MDPI
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5751230/ https://ncbi.nlm.nih.gov/pubmed/29206214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18122627 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|